XML 26 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net income $ 316,978 $ 217,120 $ 408,870
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and finance lease amortization 74,025 62,408 52,821
Amortization of intangible assets 97,743 104,194 103,320
Amortization of deferred financing costs and original issue discount 3,242 3,885 3,234
Change in fair value of investment 38,006 0 0
Loss on extinguishment of debt [1] 4,861 0 3,743
Deferred income taxes (60,615) (34,478) (95,465)
Share-based compensation expense [2] 49,248 35,492 29,481
Loss (gain) on disposal of assets 138 (285) (592)
Other noncash charges 5,780 5,922 18,339
Excess tax benefits from equity awards (5,069) (977) (16,910)
Net changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (82,816) (18,272) 6,547
Inventories 122,952 262,670 (319,274)
Other assets 546 24,266 4,766
Accounts payable 123,571 (120,900) (223,031)
Accrued wages and employee benefits 26,870 7,962 (27,369)
Other accrued liabilities 25,841 (27,337) 110,036
Net cash provided by operating activities 741,301 521,670 58,516
Investing activities      
Proceeds from sale of property and equipment 211 2,896 2,077
Proceeds from beneficial interest in securitization transactions 0 3,294 3,566
Contribution to tax equity investment (1,629) (6,627) (14,930)
Purchase of long-term investments (37,821) (32,592) (15,000)
Proceeds from sale of long-term investments 2,000 0 1,308
Expenditures for property and equipment (136,733) (129,060) (86,188)
Acquisition of businesses, net of cash acquired (34,740) (15,974) (25,065)
Net cash used in investing activities (208,712) (178,063) (134,232)
Financing activities      
Proceeds from short-term borrowings 29,219 64,257 248,209
Proceeds from long-term borrowings 541,475 348,827 1,026,284
Repayments of short-term borrowings (54,548) (37,104) (268,133)
Repayments of long-term borrowings and finance lease obligations (794,600) (288,699) (542,191)
Stock repurchases (152,743) (251,513) (345,840)
Payment of debt issuance costs (3,616) 0 (10,330)
Payment of contingent acquisition consideration 0 (4,979) (16,135)
Payment of deferred acquisition consideration (7,421) 0 0
Purchase of additional ownership interest (9,117) (104,844) (375)
Cash dividends paid to noncontrolling interest of subsidiary (273) 0 (309)
Taxes paid related to equity awards (24,769) (10,897) (40,923)
Proceeds from the exercise of stock options 27,558 7,815 13,786
Net cash (used in) provided by financing activities (448,835) (277,137) 64,043
Effect of foreign exchange rate changes on cash and cash equivalents (3,471) 1,801 (2,943)
Net increase (decrease) in cash and cash equivalents 80,283 68,271 (14,616)
Cash and cash equivalents at beginning of period 200,994 132,723 147,339
Cash and cash equivalents at end of period 281,277 200,994 132,723
Supplemental disclosure of cash flow information      
Interest 89,420 84,027 48,912
Income taxes $ 148,828 $ 100,082 $ 150,893
[1] Represents fees paid to creditors and the write-off of the unamortized original issue discount and deferred financing costs in connection with the 2024 and 2022 debt refinancings. Refer to Note 12, “Credit Agreements,” to the consolidated financial statements of this Annual Report on Form 10-K for further information on the losses on extinguishment of debt.
[2] Represents share-based compensation expense to account for stock options, restricted stock, and other stock awards over their respective vesting periods.